Floatz logo

Therapeutic Asset Ratings

18,153 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Everolimus
Breast Cancer
UNC Lineberger Comprehensive Cancer CenterP4BB (67)
Exemestane
Breast Cancer
National Cancer Institute (NCI)P4BB (67)
Ezetimibe
HIV Infectious Disease
Kirby InstituteP4BB (67)
Fluorouracilum
Breast Neoplasm
Rutgers, The State University of New JerseyP4BB (67)
Fruquintinib
Colorectal Cancer
Jiangsu Cancer Institute & HospitalP4BB (67)
Gabapentin
Morbid Obesity
Tanta UniversityP4BB (67)
Hydrocortisone
Acute Lymphoblastic Leukemia
Children's Oncology GroupP4BB (67)
Ibrutinib
Mantle Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.P4BB (67)
Ibuprofen
Morbid Obesity
Cairo UniversityP4BB (67)
Idarubicin
Acute Lymphoblastic Leukemia
Xianmin Song, MDP4BB (67)
Irinotecan
Breast Cancer
PfizerP4BB (67)
Irinotecan
Colorectal Cancer
UNICANCERP4BB (67)
Irinotecan
Ovarian Cancer
ARCAGY/ GINECO GROUPP4BB (67)
Lamotrigine
Bipolar II Disorder
University Hospital Bispebjerg and FrederiksbergP4BB (67)
Lenvatinib
Kidney Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCSP4BB (67)
Letrozole
Breast Tumor Luminal A Or B
BeOne MedicinesP4BB (67)
Letrozole
Obesity Disorder
Sultan Qaboos UniversityP4BB (67)
Letrozole
Vitamin D Deficiency
Umm Al-Qura UniversityP4BB (67)
Lidocaine
Breast Cancer
Instituto Nacional de Cancer, BrazilP4BB (67)
Lidocaine
Stroke Disorder
Institut National de la Santé Et de la Recherche Médicale, FranceP4BB (67)
Lithium, Elemental
Dementia
University of ChileP4BB (67)
Marcaine
Postherpetic Neuralgia
Shirong TanP4BB (67)
Melphalan
B-Cell Non-Hodgkin Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (67)
Melphalan
Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4BB (67)
Melphalan
Plasma Cell Myeloma
Dana-Farber Cancer InstituteP4BB (67)
Showing 2026 to 2050 of 18,153 assets
PreviousPage 82 of 727Next